Yale Biotech Club’s Post

Every four months, the No Patient Left Behind team and a small group of professionals (including me) train a cohort of NPLB fellows in the fundamentals of affordable biomedical innovation. TODAY (Sept 22) is the deadline to apply for the upcoming session. https://lnkd.in/e_VnJvBK Hundreds of fellows have already graduated. They can answer the following question correctly, even though most people, even many folks who engage in drug pricing, can’t: “how can you tell when a uniquely essential drug has been overpriced?” The NPLB Fellowship accept candidates from all walks… ranging from executives to students… scientists and doctors to attorneys and journalists. There is plenty of opportunity to engage with other fellows, the NPLB team, me, and my colleagues at RA Capital Management. And it’s not all lectures. There is asynchronous learning, discussions, and fellows work on some hands-on projects under the leadership of Sr Fellows from prior sessions. Maybe this is for you. Or maybe it’s for someone you know, in which case pass it on. And if you are interested in the material but don’t have the time to commit to the fellowship, check out the Learn tab on the NPLB website and absorb the Fundamentals you’ll find there. Peter #biotech

ICYMI: Apply now for our fall fellowship! How can medicines be both profitable to develop and affordable for patients who need them? Join students, young professionals, and future biotech leaders in a guided program that answers this question and surveys the foundations of biomedical innovation and affordability. Learn from biotech leaders and meet like-minded peers during live lectures and discussions that unite lessons on investing, drug development, health economics, and public policy—led by leaders across the biotech ecosystem. Details and application below. https://lnkd.in/eegQpzav

I want to share the Fellowship program that I just completed with No Patient Left Behind, an organization commited to generating research and educational materials that support the Biotech Social Contract. Many in the biopharma industry may already be familiar, but at a high level, the Biotech Social Contract is an idea that drugs developed by the industry should have market-based pricing for a patent-intended period of time, while relying on proper insurance for low to no out-of-pocket costs for patients. Many parts of this contract are often misunderstood and/or not practiced. An obvious example of this can be seen here in the U.S., where a poor insurance system often means that patients face unbearable costs or cannot access lifesaving treatments that should be paid for on a societal level. I think the Fellowship was most helpful to me because it taught me how to better communicate the components of this contract, while also discussing some of the challenges the biopharma industry will face over the next several years. There will be a new Fellowship cohort in the Spring of 2025 for anyone interested in the program. You can find more info about the program here: https://lnkd.in/epS_Czc9

I am thrilled to share that I have completed a comprehensive course on the Design and Conduct of Clinical Trials! This program enhanced my understanding of the end-to-end clinical research process. Grateful for the opportunity to deepen my expertise and contribute even more effectively to advancing clinical research. #ClinicalResearch #ClinicalTrials #Biotechnology #ContinuousLearning #Research

🙌Thinking about taking your research to market? Join the panel discussion 'Bridging the Gap - Taking Medical Research from Lab to Market' on September 11th from 4-6 pm with Justin Leushner in collaboration with London Economic Development Corporation (LEDC). Gain valuable insights, network with industry leaders, and discover the resources and strategies needed to bring your research to market and learn how you can contribute. 💡Some of the topics of discussion include: 🔬Navigating the path from discovery to development 🔬Overcoming regulatory and funding challenges 🔬Strategic partnerships and collaborations, and more! 💡Learn more and sign-up today! #Innovation #Commercialization #LifeScience #Technology #Ontario

hello connections, I am happy to share that "I am honored to have had the opportunity to participate in the Virtual National Conference on 'Research Methodology', with the theme 'Fostering Research and Innovation in Pharmacy: Advancing Academics and Industry Collaboration. This event provided an incredible platform to engage with leading experts in the field, learn about the latest advancements in research techniques, and explore the critical role of collaboration between academia and industry in driving innovation within the pharmacy sector. The conference highlighted the importance of research methodology as a cornerstone for advancing scientific knowledge, and I am excited to apply the insights gained to my own academic and professional journey. This experience has not only deepened my understanding of research processes but also reinforced the value of cross-sector partnerships in fostering a more innovative and impactful future for pharmacy. Looking forward to utilizing these learnings to contribute to the growth of research and innovation within the pharmacy industry. A big thanks to the organizers and speakers for making this event such a valuable learning experience! #ResearchMethodology #PharmacyInnovation #AcademicCollaboration #IndustryPartnership #PharmacyResearch #ContinuousLearning #ProfessionalDevelopment" #Pharmascope #Pharmalife

The Start-Up and Clinical Research Team finals are taking place today and tomorrow. We want to wish all those competing lots of luck. #INTCROY #clinicalresearchcompetition #internationalclinicalresearch #clinicalresearchteam #startupteam

Optimizing Bayesian Adaptive Trials with INLA: A Breakthrough in Clinical Research Reyhaneh Hosseini et.al. (2023) made significant strides in clinical trial design! By leveraging the power of Integrated Nested Laplace Approximations (INLA), they've developed a Bayesian adaptive trial that's both efficient and effective. Their approach addresses the challenges of complex outcomes and computational limitations, paving the way for more rigorous and innovative research. Want to learn more about how INLA can revolutionize your clinical trials? Let's connect! Drop a comment below or send me a message. #BayesianStatistics #ClinicalTrials #INLA #Research #Innovation https://lnkd.in/g2aaaA2i

If you’re planning to apply to the IDeA Clinical & Translational Research Network (CTR-N) or the IDeA Clinical & Translational Research Development (CTR-D) programs, don’t miss our upcoming webinars. The next application due date for both programs is October 9, 2024. The CTR-N Award program (P50) webinar will take place on August 21, 2:00-4:00 p.m. ET, and the CTR-D Award program (P20) webinar is scheduled for August 23, 2-4 p.m. ET. During the webinars, we’ll provide an overview of the notices of funding opportunities and answer any questions you may have. For more details on the upcoming webinars, check out our #NIGMSFeedbackLoop blog—link in the comments. #FundingOpportunity

For those of you that missed AACR in San Diego, the excitement is not over yet. Here are two places we can meet up this week to chat about biotech. 𝟭) 𝗨𝗖𝗦𝗗 𝗣𝗵𝘆𝘀𝗶𝗰𝗶𝗮𝗻-𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 What: Ask me anything you want about biotech careers When: Apr 11, 12:30pm - 6:00pm Where: UCSD School of Medicine, MET Courtyard [Registration closed] 𝟮) 𝗟𝗮𝘂𝗻𝗰𝗵𝗕𝗶𝗼'𝘀 𝗚𝗿𝗼𝘄𝗶𝗻𝗴 𝗬𝗼𝘂𝗻𝗴: 𝗧𝗵𝗲 𝗟𝗼𝗻𝗴𝗲𝘃𝗶𝘁𝘆 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 What: Hear from CEOs & VCs about anti-aging biotech When: April 11, 5pm-8pm Where: Creekside Labs, San Diego, CA [Registration link in comments] If you are attending either of the events above, I'd love to meet up with you in person and chat about your biotech career, or your biotech company. 👉Send me a DM and we'll schedule a time to get together. #biotech, #biotechjobs, #sandiego